These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32776967)

  • 1. Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy.
    Ritscher S; Hoyer M; Georges C; Wunder C; Wallemacq P; Persu A; Obermüller N; Toennes SW
    PLoS One; 2020; 15(8):e0237383. PubMed ID: 32776967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.
    Ritscher S; Georges C; Wunder C; Wallemacq P; Persu A; Toennes SW
    Blood Press; 2020 Oct; 29(5):291-298. PubMed ID: 32400211
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers - drug classes with low adherence in antihypertensive therapy.
    Ritscher S; Hoyer M; Wunder C; Obermüller N; Toennes SW
    Sci Rep; 2019 Oct; 9(1):15652. PubMed ID: 31666620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
    Wagmann L; Vollmer AC; Lauder L; Mahfoud F; Meyer MR
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of 21 antihypertensive drugs in serum using UHPLC-MS/MS.
    Gundersen POM; Helland A; Spigset O; Hegstad S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():84-93. PubMed ID: 29783197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC-MS/MS.
    van der Nagel BCH; Versmissen J; Bahmany S; van Gelder T; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():367-373. PubMed ID: 28666228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence.
    Richter LHJ; Jacobs CM; Mahfoud F; Kindermann I; Böhm M; Meyer MR
    Anal Chim Acta; 2019 Sep; 1070():69-79. PubMed ID: 31103169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessment.
    Punt AM; Stienstra NA; van Kleef MEA; Lafeber M; Spiering W; Blankestijn PJ; Bots ML; van Maarseveen EM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():103-110. PubMed ID: 31146083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples.
    De Nicolò A; Avataneo V; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2017 Aug; 142():279-285. PubMed ID: 28538203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients.
    De Nicolò A; Avataneo V; Rabbia F; Bonifacio G; Cusato J; Tomasello C; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2016 Sep; 129():535-541. PubMed ID: 27497654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study.
    Florczak E; Tokarczyk B; Warchoł-Celińska E; Szwench-Pietrasz E; Prejbisz A; Gosk M; Kabat M; Narkiewicz K; Januszewicz A; Kała M
    Pol Arch Med Wewn; 2015; 125(1-2):65-72. PubMed ID: 25578261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment for antihypertensive drug intake: How, where and when?].
    Bouhanick B; Fonquernie P; Bedue I; Schavgoulidze A; Gandia P
    Therapie; 2019 Dec; 74(6):651-664. PubMed ID: 31301815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study.
    Wunder C; Persu A; Lengelé JP; Mg Georges C; Renkin J; Pasquet A; Carlier M; Zhang ZY; Staessen JA;
    Blood Press; 2019 Jun; 28(3):168-172. PubMed ID: 30942111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.
    Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F
    Br J Clin Pharmacol; 2018 Nov; 84(11):2535-2543. PubMed ID: 29971815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
    Taus F; Gottardo R; Ballotari M; Utzeri C; Tagliaro F
    Drug Test Anal; 2022 Oct; 14(10):1773-1778. PubMed ID: 35855505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taste acceptability of pulverized brand-name and generic drugs containing amlodipine or candesartan.
    Uestuener P; Ferrarini A; Santi M; Mardegan C; Bianchetti MG; Simonetti GD; Milani GP; Lava SA
    Int J Pharm; 2014 Jul; 468(1-2):196-8. PubMed ID: 24746411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.